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ABSTRACT
The expression of peroxisome proliferator-activated receptor
gamma (PPARgamma) and its role in corpora lutea (CL) function
were studied in pseudopregnant rabbits. Corpora lutea were
collected at an early stage (Day 4), midstage (Day 9), and late
stage (Day 13) of pseudopregnancy. Immunohistochemistry
found evidence for the presence of PPARgamma in the
perinuclear cytoplasm and nucleus of all the luteal cells;
immunoreactivity decreased from the early to the late stage,
with immunonegativity of the nuclei of late stage CL. PPAR-
gamma mRNA transcript was expressed in all the luteal stages
with the lowest level in the late stage. In CL cultured in vitro, the
PPARgamma agonist (15-deoxy delta12,14 prostaglandin J2
[15d-PGJ2], 200 nM) increased and the antagonist (T0070907,
50 nM) decreased progesterone secretion at early and midluteal
stages, whereas 15d-PGJ2 reduced and T0070907 increased
PGF2alpha at the same stages. Prostaglandin-endoperoxide
synthase 2 (PTGS2) activity was reduced by 15d-PGJ2 and
increased by T0070907 in CL of early and midluteal stages.
Conversely, 15d-PGJ2 increased and T0070907 reduced 3beta-
hydroxysteroid dehydrogenase (3beta-HSD) activity in early and
midluteal stage CL. PGE2 in vitro secretion as well as PTGS1 and
20alpha-HSD enzymatic activities were not affected by 15d-
PGJ2 and T0070907 in any CL types. These results indicate that
PPARgamma plays a luteotropic role in pseudopregnant rabbits,
through PTGS2 down-regulation and 3beta-HSD up-regulation,
with a consequent PGF2alpha decrease and progesterone
increase.
3beta-HSD, corpora lutea, PGF2alpha, PPARgamma,
progesterone, PTGS2, rabbit
INTRODUCTION
The peroxisome proliferator-activated receptors (PPARs), a
family of three (a, d, and c) nuclear receptor/transcription
factors, are involved in several processes such as steroidogen-
esis, angiogenesis, tissue remodeling, cell cycle, and apoptosis
[1]. These processes are critical for normal ovarian function
[2], and all three PPARs have been identified in the ovary of
many species [3]. In particular, these nuclear receptors have
been localized in the ovary of the rat [2, 4], mouse [5], pig [6],
sheep [7], cow [8–10], rabbit [11], and human [12, 13]. Several
in vitro studies have shown that PPAR agonists present
contradictory actions on granulosa and luteal steroid secretion,
depending on the species [1]. PPAR mechanisms in ovarian
functions are not fully understood. However, comparisons with
other cell models suggest that PPARs may regulate the genes
required for follicle and corpora lutea (CL) maintenance [1].
It is widely accepted that prostaglandins (PGs) play a key
role in regulating CL function and life span [14]. While PGF2a
is the main luteolytic factor, PGE2 is an important luteopro-
tective factor with luteotrophic or antiluteolytic actions [15–
17]. The critical step in PG biosynthesis is the enzymatic
conversion of arachidonic acid (AA) into PGH2 by prosta-
glandin-endoperoxide synthase 1 (PTGS1) or PTGS2. PGH2,
in turn, is converted into four structurally active PGs (PGE2,
PGF2a, PGD2, and PGI2) via specific PG synthases [18].
However, the biosynthesis of PGF2a is peculiar because it
derives from three different pathways catalyzed by correspond-
ing ketoreductases using PGH2, PGD2, or PGE2 as substrates.
In many species, the CL themselves synthesize PGF2a and
PGE2, whose production is regulated by a large array of local
and systemic factors, suggesting a paracrine and autocrine role
for these two PGs [19–22].
In cardiac myocytes and in prostate cells, PPARc was found
to down-regulate the genes encoding PTGS2 [23], an enzyme
implicated in the control of ovulation and CL life span [16].
Current research is devoting considerable attention to PGD2
and PPAR; in fact, an initial screening of AA metabolites
revealed that a dehydration product of PGD2, namely the
cyclopentanone PG, 15-deoxy delta12,14 prostaglandin J2
(15d-PGJ2), is a potent PPARc ligand [2, 24]. A-series
cyclopentanone PGs (PGAs) are dehydration products of PGE2
and can bind and activate PPARd or PPARc. PGAs are not
considered a major product in the body but, conceivably, may
be present in sites where PGE2 is produced [25]. PGF2a shows
no binding to or activation of PPARs; however, PGF2a does
indirectly inhibit PPARc activity by mediating its phosphor-
ylation [25].
The rabbit CL is a good model for investigating PPARc
mechanisms that regulate luteal function because in this species
it is possible to induce pseudopregnancy by exogenous
gonadotropin-releasing hormone (GNRH) administration [26].
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Therefore, the main objective of the present study was to
examine the modulatory effects of PPARc on rabbit CL during
early, mid-, and late luteal stages of pseudopregnancy. With
this end in view, experiments were devised to clarify the
immunopresence and the gene expression of PPARc, as well as
its effects in vitro on the production of progesterone, PGE2,
and PGF2a, and on the activity of the enzymes involved in the
regulation of CL life span: 3b-hydroxysteroid dehydrogenase
(3b-HSD), 20a-HSD, PTGS1, PTGS2, and PGE2-9-ketore-
ductase (PGE2-9-K).
MATERIALS AND METHODS
Reagents and Hormones
Mouse monoclonal anti-PPARc (sc-7273) and anti-3b-HSD primary
antibodies (sc-100466) were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA). Biotin goat anti-mouse immunoglobulin G (IgG) secondary
antibody, avidin-biotin complex (ABC, Vector Elite Kit), mouse IgG, and the
chromogen 3,30-diaminobenzidine tetrachloride (DAB) were obtained from
Vector Laboratories (Burlingame, CA). The endogenous PPARc agonist 15d-
PGJ2 and the selective antagonist T0070907 (.800-fold selectivity for PPARc
over-PPARa and PPARd) [27] were purchased from Tocris Bioscience
(Bristol, U.K.).
Random hexamer primers, deoxyribonuclease I (DNAase I amplification
grade), RNAse H-reverse transcriptase (Superscript III Reverse Transciptase),
Escherichia coli RNase H, DNA ladders, the reagent for the isolation and
purification of total RNA (TRIzol), Taq DNA polymerase (Platinum), RNAse-
free tubes and water, and deoxynucleotide monophosphates were obtained from
Invitrogen (Milan, Italy). Primers for 18S rRNA and the corresponding
competimers (QuantumRNA 18S internal standards) and PPARc were also
acquired from Invitrogen. Tritiated hormones and AA were purchased from
Amersham Biosciences (Little Chalfont, Bucks, U.K.), while progesterone,
PGF2a, and PGE2 antisera, and nonradioactive hormones (NS-398, trilostane,
and R-flurbiprofen) came from Sigma (St. Louis, MO).
Incubation wells were obtained from Becton Dickinson Co. (Clifton, NJ),
while medium 199 and Earle Balanced Salt Solution were from GIBCO (Grand
Island, NY). HEPES and bovine serum albumin (BSA) were purchased from
Sigma, whereas all other pure grade chemicals and reagents were obtained
locally.
The following hormonal preparations were administered via intramuscular
injection: equine chorionic gonadotropin (Folligon; Intervet, Milan, Italy) and
GNRH analog (Buserelin; Receptal. Hoechst-Roussel Vet, Milan, Italy).
Protein concentration was determined by Bio-Rad Protein Assay Kit (Hercules,
CA).
Animals and Hormonal Regimen
Sexually mature New Zealand white female rabbits (Oryctolagus cuniculus,
3.5–4 kg body weight, and 5 mo of age), were raised n premises owned by the
University of Perugia and were used for all the experiments. The rabbits were
housed individually in wire mesh cages under controlled light (14L:10D; lights
off at 2100 h) and temperature (188C–248C) conditions. Each animal had free
access to food and water. Pseudopregnancy was induced with 20 international
units eCG followed 3 days later by 0.8 lg Buserelin [26]. The day of Buserelin
injection was designated as Day 0. At Days 4 (early stage), 9 (midstage), and 13
(late stage) of pseudopregnancy, animals (n ¼ 6 for each luteal stage) were
euthanized by cervical dislocation in compliance with the guidelines of the
Italian Ministry of Health (the national laws on animal research, DL 116/92)
and the European Communities Council directive on animal research (N. 86/
609/EEC). The protocols involving the use of the animals for these experiments
were approved by the Bioethic Committee of the University of Perugia.
Tissue Collection and Processing
Upon euthanasia, the reproductive tracts were promptly removed and
thoroughly washed with saline. Within a few minutes, all the CL were excised
from ovaries (;12 CL/ovary), and after careful dissection of nonluteal tissue by
fine forceps under stereoscopic magnification, some were immediately
processed for in vitro experiments while others were rinsed with RNAse-free
PBS and frozen at 808C for later evaluation of gene expression. For the
immunohistochemical detection of PPARc, the ovaries of two additional
animals for each luteal stage were fixed by immersion in 4% (w/v)
formaldehyde in PBS (pH 7.4) for 24 h at room temperature and subsequently
processed for embedding in paraffin following routine tissue preparation
procedures [28].
Immunohistochemistry
Immunohistochemical investigation was performed according to procedures
previously described [29, 30]. Slides were deparaffinized, rehydrated through
graded concentrations of alcohol to distilled water, and submitted to antigen
retrieval by microwaving in Tris solution (0.01 M, pH 8.5) at high power for 10
min. The slides were then cooled to room temperature. After rinsing with TBS
(Tris-buffered saline), they were dipped in 3% H
2
O
2
in methanol for 1 h to
quench the endogenous peroxidase activity and rinsed in TBS (100 mM Tris,
75 mM NaCl; pH 7.4). Background labeling was prevented by incubating the
sections with normal goat serum diluted 1:10 for 1 h at room temperature. The
slides were then incubated overnight at 48C in a moist chamber with the anti-
PPARc and anti-3b-HSD primary antibodies diluted 1:50 in TBS containing
0.2% Triton X-100 and 0.1% BSA. The next day, the slides were rinsed in
TBS, treated again with normal goat serum and incubated with biotin goat anti-
mouse secondary antibody diluted 1:200 for 30 min at room temperature. After
TBS washes, the slides were exposed to the ABC kit for 30 min and rinsed
again with TBS. The peroxidase activity sites were visualized using the DAB
kit as the chromogen; the sections were rinsed with distilled water, washed in
running tap water, dehydrated by passing through graded ethanol (70%, 95%,
and 100% vol/vol) solutions, cleared in xylene, and, finally, mounted with
Eukitt medium for light microscopy. Tissue sections in which the primary
antibody was omitted or substituted by mouse IgG were used as negative
controls of nonspecific staining. The intensity of immunostaining was assessed
and compared microdensitometrically as previously described [31] using an
image analysis system (IAAS 2000 image analyzer, Delta Sistemi, Rome,
Italy).
RT-PCR
Total RNA was extracted from CL of three rabbits for each luteal stage as
previously described [17]. Total RNA (5 lg) were reverse transcribed in 20 ll
of SuperScript III Reverse Transcriptase cDNA synthesis mix using random
hexamer according to the protocol provided by the manufacturer. Genomic
DNA contamination was checked by developing the PCR without reverse
transcriptase. Multiplex PCR amplification was carried out as previously
described [17] using 1 ll of luteal cDNA as the template for the target (Table 1)
and 18S primers. Cycling conditions consisted of an initial denaturizing cycle at
948C for 75 sec, followed by 35 cycles for each target gene at 948C for 15 sec,
608C for 30 sec, 728C for 45 sec, and a final extension step at 728C for 10 min.
Within each experiment, the complete set of samples was processed in parallel
in a single PCR, using aliquots of the same PCR master mix. The amplified
PCR-generated products (20 ll of 25 ll total reaction volume) were analyzed
by electrophoresis on 2% agarose gel using ethidium bromide staining.
Analysis of amplification products was carried out as reported elsewhere [17].
The amplified products, collected from agarose gel after electrophoresis, were
purified with Nucleospin Extract II kit, and their identities were confirmed by
DNA sequencing using the Sanger method.
In Vitro Experiments
A method previously reported was used for the in vitro study [32, 33].
Early, mid-, or late stage CL were randomly distributed into incubation wells in
1 ml of culture medium 199 with Earle Balanced Salt Solution containing 2.2
mg/ml sodium bicarbonate, 2.3mg/ml HEPES, and 3% BSA (w/v). Before the
treatment, the CL were quartered inside each well (one quartered CL/well)
using fine forceps. Each set of incubation wells was divided into three
experimental groups, each formed of five wells as follows: (I) medium alone as
control, (II) PPARc agonist (15d-PGJ2, 200 nM), and (III) PPARc antagonist
(T0070907, 50 nM). The culture plates were incubated at 378C in air with 5%
CO
2
. The media of each well were collected after 4 h of incubation and stored
TABLE 1. Primers for PPARc and 18S used as internal standard for RT-
PCR quantification.
Gene Product size Primers (50–30)a
PPARc 200 bp F: TGAAGGATGCAAGGGTTTCT
R: CCAACAGCTTCTCCTTCTCG
18S 489 bp F: TCAAGAACGAAAGTCGGAGGTT
R: GGACATCTAAGGGCATCA
a F, forward; R, reverse.
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immediately at 208C for later determination of progesterone, PGF2a, and
PGE2 well concentrations. Corpora lutea pieces were weighed and protein
concentration was determined by an assay kit. Preliminary evidence led to our
choice of the incubation conditions and the minimum effective dose for PPARc
agonist and antagonist used in the present in vitro study (Fig. 1).
Hormone Determination
Progesterone, PGF2a, and PGE2 concentrations were determined following
the radioimmunoassay (RIA) protocols previously reported [32]. Intra- and
interassay coefficients of variation and minimum detectable doses were:
progesterone, 6.1%, 8.9%, and 11 pg/tube; PGF2a, 7.5%, 12.4%, and 18 pg/
tube; and PGE2, 6.4%, 12.2%, and 16 pg/tube.
Enzyme Activity Determination
The activities of PTGS1 and PTGS2 were determined by measuring the
disappearance of the radiolabeled substrate [3H] AA using a method previously
reported [21, 34]. A selective PTGS2 inhibitor (NS-398, 1 lM) and
nonselective PTGS inhibitor (acetylsalicylic acid, 1 mM) were used. For each
sample, PTGS1 activity was determined by calculating the rate of loss of [3H]
AA incubated with the selective PTGS2 inhibitor. Conversely, the PTGS2
activity of each corresponding sample was determined by calculating the rate of
loss of [3H] AA incubated without the selective PTGS2 inhibitor and
subtracting from this the value of the PTGS1 activity. The values for PTGS1
and PTGS2 were corrected by subtracting [3H] AA disappearance resulting
from other enzymatic activities and nonenzymatic reactions. The activity of
PGE2-9-K was determined by measuring the conversion of [3H] PGE2 into
[3H] PGF2a using a previously reported modified method [21].
The activity of 3b-HSD was determined by measuring the conversion of
[3H] pregnenolone into [3H] progesterone. Briefly, each pool of CL was
homogenized in 1 ml cold fresh homogenizing buffer (20 mM K
2
HPO
4
, 1 mM
ethylenediaminetetraacetic acid [EDTA] and 10 mM b-mercaptoethanol, pH
7.4). The total homogenate was filtered and immediately used for the assay of
enzymatic activity. One hundred microliters of homogenate and 50 ll of
homogenizing buffer containing 150 000 decompositions/min (d.p.m.) [3H]
pregnenolone and NADPH (3 mg/ml) were added to the incubation tube. The
mixture was incubated at 378C for 10 min. Termination was achieved by the
addition of 100 ll 0.1 M HCl. Steroids were extracted with diethyl ether and
resuspended with 500 ml RIA buffer (74.5 mM Na
2
HPO
4
, 12.5 mM sodium
EDTA, 0.1% gelatin, pH 7.5). Two hundred microliters RIA buffer containing
progesterone-specific antiserum were added to duplicate samples, and the
FIG. 1. In vitro effects of increasing concentrations of PPARc agonist (15d-PGJ2) and antagonist (T0070907) on progesterone release by rabbit CL
collected at early stage (Day 4), midstage (Day 9), and late stage (Day 13) of pseudopregnancy. Values are the means 6 SD of six samples. Asterisks
indicate a significantly different value (P , 0.01) versus control (0 nM).
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mixture was incubated at 48C for 16 h. The [3H] progesterone-antiserum bound
fraction was separated with charcoal-dextran suspension, and the radioactivity
was quantified by liquid scintillation counting. The sample and substrate
mixture with a specific 3b-HSD inhibitor (trilostane, 1 mM) was used to
determine the [3H] progesterone synthesis resulting from other enzymatic
activities and nonenzymatic reactions. The values for 3b-HSD were corrected
by subtracting the values due to other enzymatic activities and nonenzymatic
reactions.
The activity of 20a-HSD was determined by measuring the residual level of
[3H] progesterone in a homogenate of incubated CL. Briefly, 100 ll of CL
homogenate and 50 ll of homogenizing buffer containing 150 000 d.p.m. [3H]
progesterone were added to the incubation tube. The mixture was incubated at
378C for 10 min. Termination was achieved by the addition of 100 ll 0.1 M
HCl. The [3H] progesterone-antiserum bound fraction was quantified as
reported above for 3b-HSD. The sample and substrate mixture with a specific
20a-HSD inhibitor (R-flurbiprofen, 1 mM) was used to determine the [3H]
progesterone disappearance resulting from other enzymatic activities and
nonenzymatic reactions. The values for 20a-HSD were corrected by subtracting
the values due to other enzymatic activities and nonenzymatic reactions.
Statistical Analysis
All the data were examined by Levene test, which showed statistically
significant homoscedasticity for all of the variables. Data were analyzed using
two-way ANOVA (treatments vs. CL stages, Table 2) followed by Student-
Newman-Keuls t-test. Differences were considered significant at P , 0.01.
RESULTS
Immunohistochemistry
Intense PPARc immunoreactivity was localized in the
perinuclear cytoplasm and, with lesser intensity, in the nucleus
of all the luteal cells at the early stage of pseudopregnancy
(Fig. 2, A and B). The density of immune reactive cells
decreased (P , 0.01) from the early to late stage (Fig. 2, C, D,
and G); in particular, the majority of the luteal cell nuclei were
immunonegative at the late stage (Fig. 2D). The wall of blood
vessels (endothelial, stromal, and smooth muscle cells) was
always negative (Fig. 2E). No staining was detectable in
negative control rabbit CL in which the primary antibody was
omitted or substituted with mouse IgG (Fig. 2F).
Expression of mRNA for Luteal PPARc
PPARc transcript was expressed in CL at different stages of
pseudopregnancy with the lowest abundance (P , 0.01) at the
late stage of pseudopregnancy (Fig. 3, upper panel).
In Vitro Hormone Production
Basal progesterone production of midstage CL was higher
(P , 0.01) than that of both early and late stages CL, and
secretion by late stage CL was higher (P , 0.01) than that of
the early ones (Fig. 4, upper panel). The PPARc agonist 15d-
PGJ2 increased (P , 0.01) and the antagonist T0070907
reduced (P , 0.01) in vitro progesterone secretion in early and
midluteal stages of pseudopregnancy (Fig. 4, upper panel).
Basal PGF2a secretion was higher in late CL (P , 0.01)
than in the early and midluteal stages, and secretion by
midstage CL was higher (P , 0.01) than that of early ones
(Fig. 4, middle panel). The PPARc agonist 15d-PGJ2 reduced
(P , 0.01) and the antagonist T0070907 increased (P , 0.01)
PGF2a secretion in early and midluteal stages of pseudopreg-
nancy (Fig. 4, middle panel).
Basal PGE2 secretion was higher in early CL stage (P ,
0.01) than in midluteal and late stages, and secretion by late CL
stage was higher (P , 0.01) than that of midstage CL (Fig. 4,
lower panel). Both 15d-PGJ2 and T0070907 did not modify
PGE2 in vitro secretion in any luteal stage (Fig. 4, lower
panel).
Luteal Enzyme Activities
Basal PTGS1 activity was higher in the late CL stage (P ,
0.01) than in early and midstages (Fig. 5, upper panel), whereas
PTGS2 activity significantly increased (P , 0.01) with the
progress of the CL stages (Fig. 5, middle panel). Both 15d-
PGJ2 and T0070907 did not affect PTGS1 activity in any CL
types (Fig. 5, upper panel), while 15d-PGJ2 reduced (P ,
0.01) PTGS2 activity at early stage of pseudopregnancy and
T00070907 increased it (P , 0.01) at the midstage (Fig. 5,
middle panel).
Basal PGE2-9-K activity of late stage CL was higher (P ,
0.01) than that of early and midstages, and the activity of
midstage CL was higher (P , 0.01) than that of the early ones
(Fig. 5, lower panel). Both 15d-PGJ2 and T0070907 did not
affect PGE2-9-K activity in any CL type (Fig. 5, lower panel).
Basal 3b-HSD activity was higher in midstage CL (P ,
0.01) than in early and late stage CL, and activity in late stage
CL was lower (P , 0.01) than that of early ones (Fig 6, upper
panel). The agonist 15d-PGJ2 increased (P , 0.01) and the
antagonist T0070907 reduced (P , 0.01) 3b-HSD activity at
early and midstages of pseudopregnancy (Fig. 6, upper panel).
Basal 20a-HSD activity was lower in midstage CL (P ,
0.01) than in early and late stage CL, and the activity of late
stage CL was higher (P , 0.01) than that of early ones (Fig. 6,
lower panel). Both 15d-PGJ2 and T0070907 did not affect
20a-HSD activity in any CL types (Fig. 6, lower panel).
DISCUSSION
The present study provides evidence for the first time of the
presence of PPARc in rabbit CL. The results indicate that this
nuclear transcription factor may well be another likely
candidate for the list of factors known to be involved in
luteotropic function.
Several studies have reported the occurrence of PPARc in
mammalian ovary; this nuclear receptor has been found in the
granulosa and theca cells and also in CL of rodents and
ruminants [7, 35, 36]. In addition, PPARc was detected in
primary and secondary follicles, being more expressed in the
large follicles and decreasing with the LH surge [2, 7, 36]. In
bovine CL, PPARc gene and protein expressions increased
after ovulation, but decreased if no fertilization or embryo
implantation occurred [37, 38].
Our immunohistochemical results demonstrated the pres-
ence of PPARc in the cytoplasm and nuclei of all luteal cells
during the three stages of pseudopregnancy examined. Of note,
in late stage CL, the majority of nuclei were immunonegative.
This finding was partly supported by the results on gene
expression; indeed, PCR showed the lowest amounts of PPARc
TABLE 2. Two-way ANOVA F values: treatments (control, 15d-PGJ2,
T0070907) versus CL stages (early, mid, late).a
Parameter Treatments CL stages Interaction
Progesterone 17.12* 26.23* 1.24
PGF2a 26.09* 18.23* 2.31
PGE2 3.12 33.62* 0.89
PTGS1 2.58 15.99* 1.32
PTGS2 37.15* 26.04* 2.46
PGE2-9-K 3.51 16.27* 2.74
3b-HSD 24.39* 18.92* 2.38
20a-HSD 2.65 10.52* 1.16
a Degrees of freedom: treatments, 2; CL stages, 2; interaction, 4; error, 45;
*P , 0.01.
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FIG. 2. Immunohistochemical detection of PPARc in rabbit CL collected at early stage (Day 4), midstage (Day 9), and late stage (Day 13) of
pseudopregnancy. A, B) Early CL: the immunosignals are intensely localized in the perinuclear cytoplasm and nucleus of luteal cells (LC) with B at a
higher magnification of A. C) Midstage CL: a decrease of the immunosignals in luteal cells is evident. D) Late stage CL: the majority of the luteal cell nuclei
are immunonegative. E) Early stage CL: the wall of the blood vessels (arrows) are immunonegative. F) Early stage CL: section of negative control. Bars¼20
lm. G) Immunodensitometry: data are expressed in arbitrary units; values for each luteal stage are the means6 SD of 20 slides; and different letters above
the bars indicate significantly different values (P , 0.01).
PPARGAMMA FUNCTION IN RABBIT CORPORA LUTEA
5 Article 62
D
ow
nloaded from
 w
w
w
.biolreprod.org. 
mRNA in late CL. Even if the protein and gene presence did
not necessarily imply a role, results indicate that PPARc has a
role in regulating the CL life span. In this context, PPARc
tissue-specific deletion in mouse ovary led to a decrease in
fertility [5], and Froment et al. [1] found that PPARc plays a
significant role in fertility control, preserving CL function
during pregnancy.
Komar [2] reported that PPARc activation affects proges-
terone production by ovarian cells. In particular, 15d-PGJ2, an
endogenous activator of PPARc, inhibited the basal and
gonadotropin-stimulated progesterone production in human
granulosa cells [39], whereas 15d-PGJ2 and ciglitazone, a
synthetic PPARc activator, increased the granulosa cell
progesterone secretion in eCG-primed immature rats [36].
Porcine theca and bovine luteal cells also showed an increase
of progesterone production after PPARc activation by 15d-
PGJ2, ciglitazone, or troglitazone, another synthetic activator,
[6, 37]. These studies clearly demonstrate that the effect of
PPARc on progesterone synthesis depends on cell type, stage
of cell differentiation, stage of the ovarian cycle, and/or animal
species [2].
The present research showed that 15d-PGJ2 induced an
increase of progesterone production in early and midluteal
stage CL cultured in vitro, whereas the inhibitor T0070907
displayed the opposite effect. In contrast, late stage CL were
not affected by 15d-PGJ2 or by T0070907 in vitro treatments.
The lack of effects by PPARc activator and inhibitor in late
stage CL may depend on the disappearance of PPARc in the
nucleus of most luteal cells at this stage of pseudopregnancy, as
indirectly demonstrated by immunohistochemical and gene
expression results.
Various studies used thiazolidinediones (TZDs), a class of
PPARc activators employed as drugs in diabetes mellitus, to
evaluate the effects of this nuclear receptor on the synthesis of
ovarian steroid hormones and the expression of many rate-
FIG. 3. Expression profile of PPARc mRNA in rabbit CL collected at early
stage (Day 4), midstage (Day 9), and late stage (Day 13) of pseudopreg-
nancy. The lower panel shows a representative photograph of a 2%
agarose ethidium bromide-stained gel used to analyze the PCR products.
The sizes of the amplified products are shown on the left of the gel. Lane
LD is the kilobase DNA marker, lane H
2
O represents a water control
(substitution of water for the template), and lane þ is a positive control
(rabbit kidney for the template). The other lanes identify the corresponding
stages of pseudopregnancy. The upper panel shows the data derived from
densitometric analyses of the gels. For each luteal stage, the values (means
6 SD) combine the results from three different rabbits and are reported in
arbitrary units of PPARc mRNA relative to that of 18S used as an internal
standard. Different letters above the bars indicate significantly different
values (P , 0.01).
FIG 4. In vitro effects of PPARc agonist (15d-PGJ2) and antagonist
(T0070907) on progesterone, PGF2a, and PGE2 releases by rabbit CL
collected at early stage (Day 4), midstage (Day 9), and late stage (Day 13)
of pseudopregnancy. Values are the means 6 SD of six samples. Different
letters above the bars indicate significantly different values (P , 0.01):
Greek letters among the control CL stages; Latin letters among the
experimental groups of the same CL stages.
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limiting steroidogenic enzymes [3]. In particular, 3b-HSD
activity was inhibited by troglitazone in porcine granulosa cells
[40], whereas, other authors argued that TZD treatment did not
affect 3b-HSD mRNA levels in porcine granulosa cells and
protein concentrations in ovine granulosa cells [41, 42].
In contrast, our data demonstrated that PPARc affects the
3b-HSD activity because 15d-PGJ2, increased and T007090
diminished the activity of this steroidogenic enzyme in early
and midstages CL. It is interesting to note that neither the
activator nor the inhibitor of PPARc had any effects on 3b-
HSD activity during the late luteal stage. Furthermore, 20a-
HSD enzymatic activity was not modified by 15d-PGJ2 or by
T0070907 in any luteal stage.
The molecular mechanisms of PPARc in ovarian functions
are not well understood, notwithstanding the suggestion that
PPARc can directly influence PTGS2 gene expression [1]. In
fact, the PTGS2 promoter region contains a PPARc response
element [43]. On the other hand, there are conflicting studies
that report both PPARc stimulating [40] and inhibiting [44, 45]
effects on PTGS2 gene expression.
The present study found evidence for PPARc down-
regulation of PTGS2 luteal activity at both the early and
midstages of pseudopregnancy, as suggested by the coherent
effects induced by 15d-PGJ2 and the opposite ones by
T0070907. Our data indirectly indicate that this PTGS2
down-regulation may cause a decrease of PGF2a in vitro
secretion by early and midstages CL, whereas neither PTGS1
activity nor PGE2 release were modified. In rabbit CL, PGE2-
9-K has a modulator role that correlates its enzymatic activity
with PGE2 and PGF2a synthesis negatively and positively,
respectively [21]. Wintergalen et al. [46] found that in the
rabbit, luteal PGE2-9-K also exerts an effect on 20a-HSD
catalytic activity, thus favoring the conversion of progesterone
into the inactive metabolite 20a-OH-progesterone, with a clear
luteolytic effect. Interestingly, these results for 20a-HSD and
FIG. 5. In vitro effects of PPARc agonist (15d-PGJ2) and antagonist
(T0070907) on PTGS1, PTGS2, and PGE2-9-K activities of rabbit CL
collected at early stage (Day 4), midstage (Day 9), and late stage (day 13)
of pseudopregnancy. The enzyme activities were linear with time and
amount of protein. Substrate conversion: PTGS1, early 18%, mid 21%,
late 44%; PTGS2, early 7%, mid 52%, late 8%; PGE2-9-K, early 4%, mid
16%, late 46%. Values are the means6 SD of six samples. Different letters
above the bars indicate significantly different values (P , 0.01): Greek
letters among the control CL stages; Latin letters among the experimental
groups of the same CL stages.
FIG. 6. In vitro effects of PPARc agonist (15d-PGJ2) and antagonist
(T0070907) on 3b-HSD and 20a-HSD activities of rabbit CL collected at
early stage (Day 4), midstage (Day 9), and late stage (Day 13) of
pseudopregnancy. The enzyme activities were linear with time and
amount of protein. Substrate conversion: 3b-HSD, early 19%, mid 33%,
late 10%; 20a-HSD, early 18%, mid 8%, late 27%. Values are the means
6 SD of six samples. Different letters above the bars indicate significantly
different values (P , 0.01): Greek letters among the control CL stages;
Latin letters among the experimental groups of the same CL stages.
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PGE2-9-K activity fit with similar findings in the endometrium
[47] and placentomes [48] of bovine. As we found for 20a-
HSD, PGE2-9-K activity was not modified by 15d-PGJ2 or
T0070907 treatments in any luteal stage.
In conclusion, our research found evidence for a possible
luteotropic role for PPARc in the pseudopregnant rabbit, with a
mechanism that involves the up-regulation of 3b-HSD and the
increase of progesterone as well as the down-regulation of the
luteolytic factor PGF2a and its correlated enzyme PTGS2 [21].
This hypothetical mechanism is further supported by the clear
reduction of the presence of PPARc in the nucleus of luteal
cells in late stage4 CL, a reduction that could be required for
luteolysis. However, although the present data shed new light
on possible PPARc physiological mechanisms regulating luteal
activity of mammals, further studies are needed to better
understand the fine-tuning of this nuclear receptor in
controlling the luteal life span.
ACKNOWLEDGMENT
The authors gratefully acknowledge the revision of the English text by
Sheila Beatty.
REFERENCES
1. Froment P, Gizard F, Defever D, Staels B, Dupont J, Monget P.
Peroxisome proliferator-activated receptors in reproductive tissues: from
gametogenesis to parturition. J Endocrinol 2006; 189:199–209.
2. Komar CM. Peroxisome proliferator-activated receptors (PPARs) and
ovarian function—implications for regulating steroidogenesis, differenti-
ation, and tissue remodelling. Reprod Biol Endocrinol 2005; 3:41.
3. Minge CE, Robker RL, Norman RJ. PPAR gamma: coordinating
metabolic and immune contributions to female fertility. PPAR Res
2008; 2008:243791.
4. Braissant O, Foufelle F, Scotto C, Dauc¸a M, Wahli W. Differential
expression of peroxisome proliferator-activated receptors (PPARs): tissue
distribution of PPAR-a, -b, and -c in the adult rat. Endocrinology 1996;
137:354–366.
5. Cui Y, Miyoshi K, Claudio E, Siebenlist UK, Gonzalez FJ, Flaws J,
Wagner KU, Hennighausen L. Loss of the peroxisome proliferation-
activated receptor c (PPARc) does not affect mammary development and
propensity for tumor formation but leads to reduced fertility. J Biol Chem
2002; 277:17830–17835.
6. Schoppee PD, Garmey JC, Veldhuis JD. Putative activation of the
peroxisome proliferator-activated receptor c impairs androgen and
enhances progesterone biosynthesis in primary cultures of porcine theca
cells. Biol Reprod 2002; 66:190–198.
7. Froment P, Fabre S, Dupont J, Pisselet C, Chesneau D, Staels B, Monget
P. Expression and functional role of peroxisome proliferator-activated
receptor-c in ovarian folliculogenesis in the sheep. Biol Reprod 2003; 69:
1665–1674.
8. Lo¨hrke B, Viergutz T, Shahi SK, Po¨hland R, Wollenhaupt K, Goldammer
T, Walzel H, Kanitz W. Detection and functional characterisation of the
transcription factor peroxisome proliferator-activated receptor c in lutein
cells. J Endocrinol 1998; 159:429–439.
9. Sundvold H, Brzozowska A, Lien S. Characterisation of bovine
peroxisome proliferator-activated receptors c1 and c2: genetic mapping
and differential expression of the two isoforms. Biochem Biophys Res
Comm 1997; 239:857–861.
10. Parillo F, Catone G, Gobbetti A, Zerani M. Cell localization of ACTH,
dopamine, and GnRH receptors and PPARc in bovine corpora lutea during
diestrus. Acta Sci Vet 2013; 41:e1129.
11. Maranesi M, Zerani M, Parillo F, Brecchia G, Gobbetti A, Boiti C. Role of
peroxisome proliferator-activated receptor gamma in corpora lutea of
pseudopregnant rabbits. In: Abstracts of 15th Annual Conference of the
European-Society-for-Domestic-Animal-Reproduction (ESDAR), Septem-
ber 15–17, 2011, Antalya, Turkey. Reprod Domest Anim 2011;
46(Supplement 3):26.
12. Lambe KG, Tugwood JD. A human peroxisome-proliferator-activated
receptor-c is activated by inducers of adipogenesis, including thiazalidi-
nedione drugs. Eur J Biochem 1996; 239:1–7.
13. Mu YM, Yanase T, Nishi Y, Waseda N, Oda T, Tanaka A, Takayanagi R,
Nawata H. Insulin sensitizer, troglitazone, directly inhibits aromatase
activity in human ovarian granulosa cells. Biochem Biophys Res Comm
2000; 271:710–713.
14. Niswender GD, Juengel JL, Silva PJ, Rollyson MK, McIntush EW.
Mechanisms controlling the function and life span of the corpus luteum.
Physiol Rev 2000; 80:1–29.
15. Davis JS, Rueda BR. The corpus luteum: an ovarian structure with
maternal instincts and suicidal tendencies. Front Biosci 2002; 7:
d1949–d1978.
16. Wiltbank MC, Ottobre JS. Regulation of intraluteal production of
prostaglandins. Reprod Biol Endocrinol 2003; 1:91.
17. Boiti C, Guelfi G, Brecchia G, Dall’Aglio C, Ceccarelli P, Maranesi M,
Mariottini C, Zampini D, Gobbetti A, Zerani M. Role of endothelin-1
system in the luteolytic process of pseudopregnant rabbits. Endocrinology
2005; 146:1293–1300.
18. Helliwell RJA, Adams LF, Mitchell MD. Prostaglandin synthases: recent
developments and a novel hypothesis. Prostaglandins Leukot Essent Fatty
Acids 2004; 70:101–113.
19. Boiti C, Zerani M, Zampini D, Gobbetti A. Nitric oxide synthase activity
and progesterone release by isolated corpora lutea of rabbits in early and
mid-luteal phase of pseudopregnancy are differently modulated by
prostaglandin E2 and prostaglandin F2a via adenylate cyclase and
phospholipase C. J Endocrinol 2000; 164:179–186.
20. Arosh JA, Banu SK, Chapdelaine P, Madore E, Sirois J, Fortier MA.
Prostaglandin biosynthesis, transport and signaling in corpus luteum: a
basis for autoregulation of luteal function. Endocrinology 2004; 145:
2551–2560.
21. Zerani M, Dall’Aglio C, Maranesi M, Gobbetti A, Brecchia G, Mercati F,
Boiti C. Intraluteal regulation of prostaglandin F2alpha-induced prosta-
glandin biosynthesis in pseudopregnant rabbits. Reproduction 2007; 133:
1005–1016.
22. Zerani M, Catone G, Maranesi M, Gobbetti A, Boiti C, Parillo F.
Gonadotropin-releasing hormone 1 directly affects corpora lutea life-span
in Mediterranean buffalo (Bubalus bubalis) during diestrus: presence and
in vitro effects on enzymatic and hormonal activities. Biol Reprod 2012;
87:1–8.
23. Mendez M, LaPointe MC. PPARgamma inhibition of cyclooxygenase-2,
PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes.
Hypertension 2003; 42:844–850.
24. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM.
15-deoxy-D12, 14-prostaglandin J2 is a ligand for the adipocyte
determination factor PPARc. Cell 1995; 83:803–812.
25. Bishop-Bailey D, Wray J. Peroxisome proliferator-activated receptors: a
critical review on endogenous pathways for ligand generation. Prosta-
glandins Other Lipid Mediat 2003; 71:1–22.
26. Stradaioli G, Verini Supplizi A, Monaci M, Canali C, Boiti C. Effects of
different doses of PMSG on ovarian response and in vitro embryo
development in rabbit. World Rabbit Sci 1997; 5:143–148.
27. Lee G, Elwood F, McNally J, Weiszmann J, Lindstrom M, Amaral K,
Nakamura M, Miao S, Cao P, Learned RM, Chen JL, Li Y. T0070907, a
selective ligand for peroxisome proliferator-activated receptor gamma,
functions as an antagonist of biochemical and cellular activities. J Biol
Chem 2002; 277:19649–19657.
28. Parillo F, Catone G, Maranesi M. Immunolocalization, gene expression,
and enzymatic activity of cyclooxygenases, prostaglandin e2-9-ketore-
ductase, and nitric oxide synthases in Mediterranean buffalo (Bubalus
bubalis) corpora lutea during diestrus. Microsc Res Tech 2012; 75:
1682–1690.
29. Parillo F, Catone G, Boiti C, Zerani M. Immunopresence and enzymatic
activity of nitric oxide synthases, cyclooxygenases and PGE2-9-ketor-
eductase and in vitro production of PGF2a, PGE2 and testosterone in the
testis of adult and prepubertal alpaca (Lama pacos). Gen Comp Endocrinol
2011; 171:381–388.
30. Zerani M, Catone G, Quassinti L, Maccari E, Bramucci M, Gobbetti A,
Maranesi M, Boiti C, Parillo F. In vitro effects of GnRH on Leydig cells of
adult alpaca (Lama pacos) testis: GnRH receptor immunolocalization,
testosterone and prostaglandin synthesis, and cyclooxygenase activities.
Dom Anim Endocrinol 2011; 40:51–59.
31. Zerani M, Parillo F, Brecchia G, Guelfi G, Dall’Aglio C, Lilli L, Maranesi
M, Gobbetti A, Boiti C. Expression of type I GNRH receptor and in vivo
and in vitro GNRH-I effects in corpora lutea of pseudopregnant rabbits. J
Endocrinol 2010; 207:289–300.
32. Boiti C, Zampini D, Zerani M, Guelfi G, Gobbetti A. Prostaglandin
receptors and role of G protein-activated pathways on corpora lutea of
pseudopregnant rabbit in vitro. J Endocrinol 2001; 168:141–151.
33. Parillo F, Dall’Aglio C, Brecchia G, Maranesi M, Polisca A, Boiti C,
Zerani M. Aglepristone (RU534) effects on luteal function of pseudo-
ZERANI ET AL.
8 Article 62
D
ow
nloaded from
 w
w
w
.biolreprod.org. 
pregnant rabbits: steroid receptors, enzymatic activities, and hormone
productions in corpus luteum and uterus. Anim Reprod Sci 2013; In press.
34. Zerani M, Catone G, Betti G, Parillo F. Immunopresence and functional
activity of prostaglandin-endoperoxide synthases and nitric oxide
synthases in bovine corpora lutea during diestrus. Folia Morphol 2013:
In press.
35. Gasic S, Bodenburg Y, Nagamani M, Green A, Urban RJ. Troglitazone
inhibits progesterone production in porcine granulosa cells. Endocrinology
1998; 139:4962–4966.
36. Komar CM, Braissant O, Wahli W, Curry TE Jr. Expression and
localization of PPARs in the rat ovary during follicular development and
the periovulatory period. Endocrinology 2001; 142:4831–4838.
37. Lsˇhrke B, Viergutz T, Shahi SK, Po¨hland R, Wollenhaupt K, Goldammer
T, Walzel H, Kanitz W. Detection and functional characterisation of the
transcription factor peroxisome proliferator-activated receptor gamma in
lutein cells. J Endocrinol 1998; 159:429–439.
38. Viergutz T, Lsˇhrke B, Poehland R, Becker F, Kanitz W. Relationship
between different stages of the corpus luteum and the expression of the
peroxisome proliferator-activated receptor gamma protein in bovine large
lutein cells. J Reprod Fertil 2000; 118:153–161.
39. Willis DS, White J, Brosens S, Franks S. Effect of 15-deoxy-delta (12,14)-
prostaglandin J2 (PGJ2) a peroxisome proliferator activating receptor c
(PPARc) ligand on human ovarian steroidogenesis. Endocrinology 1999;
140(suppl 1):491.
40. Gasic S, Nagamani M, Green A, Urban RJ. Troglitazone is a competitive
inhibitor of 3 beta-hydroxysteroid dehydrogenase enzyme in the ovary.
Am J Obst Gynecol 2001; 184:575–579.
41. Doney A, Fischer B, Frew D, Cumming A, Flavell DM, World M,
Montgomery HE, Boyle D, Morris A, Palmer CN. Haplotype analysis of
the PPARc Pro12Ala and C1431T variants reveals opposing associations
with body weight. BMC Genetics 2002; 3:21.
42. Ek J, Andersen G, Urhammer SA, Hansen L, Carstensen B, Borch-
Johnsen K, Drivsholm T, Berglund L, Hansen T, Lithell H, Pedersen O.
Studies of the Pro12Ala polymorphism of the peroxisome proliferator-
activated receptor-c2 (PPAR-c2) gene in relation to insulin sensitivity
among glucose tolerant caucasians. Diabetologia 2001; 44:1170–1176.
43. Meade E, McIntyre T, Zimmerman G, Prescott S. Peroxisome proliferators
enhance cyclooxygenase-2 expression in epithelial cells. J Biol Chem
1999; 274:8328–8334.
44. Subbaramaiah K, Liu DT, Hart JC, Dannenberg AJ. Peroxisome
proliferator-activated receptor c ligands suppress the transcriptional
activation of cyclooxygenase-2. J Biol Chem 2001; 276:12440–12448.
45. Inoue H, Tanabe T, Umesono K. Feedback control of cyclooxygenase-2
expression through PPARc. J Biol Chem 2000; 275:28028–28032.
46. Wintergalen N, Thole HH, Galla HJ, Schlegel W. Prostaglandin-E2 9-
reductase from corpus luteum of pseudopregnant rabbit is a member of the
aldo-keto reductase superfamily featuring 20alpha-hydroxysteroid dehy-
drogenase activity. Eur J Biochem 1995; 15:264–270.
47. Madore E, Harvey N, Parent J, Chapdelaine P, Arosh JA, Fortier MA. An
aldose reductase with 20 alpha-hydroxysteroid dehydrogenase activity is
most likely the enzyme responsible for the production of prostaglandin F2
alpha in the bovine endometrium. J Biol Chem 2003; 278:11205–11212.
48. Schuler G, Teichmann U, Kowalewski MP, Hoffmann B, Madore E,
Fortier MA, Klisch K. Expression of cyclooxygenase-II (COX-II) and 20
alpha-hydroxysteroid dehydrogenase (20 alpha-HSD)/prostaglandin F-
synthase (PGFS) in bovine placentomes: implications for the initiation of
parturition in cattle. Placenta 2006; 27:1022–1029.
PPARGAMMA FUNCTION IN RABBIT CORPORA LUTEA
9 Article 62
D
ow
nloaded from
 w
w
w
.biolreprod.org. 
